Mutations in exon 2 showed a particularly high rate of somatic alterations (70% of uterine leiomyomas) [64] and have been shown to disrupt the direct interaction of MED12 with the cyclin C-CDK8 leading to reduced Mediator activity [66]. The gene discussed is MED12; the disease is Uterine leiomyoma.